A.I.dvisor tells us that CANF and LGVN have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CANF and LGVN's prices will move in lockstep.
Ticker / NAME | Correlation To CANF | 1D Price Change % | ||
---|---|---|---|---|
CANF | 100% | N/A | ||
LGVN - CANF | 33% Poorly correlated | +0.98% | ||
RNA - CANF | 30% Poorly correlated | -6.84% | ||
XENE - CANF | 26% Poorly correlated | -0.47% | ||
VRNA - CANF | 25% Poorly correlated | -0.98% | ||
ZLAB - CANF | 25% Poorly correlated | -2.96% | ||
More |
Ticker / NAME | Correlation To CANF | 1D Price Change % |
---|---|---|
CANF | 100% | N/A |
diseases theme (42 stocks) | 24% Poorly correlated | +1.03% |
cancer theme (87 stocks) | 23% Poorly correlated | +0.89% |
drugs theme (265 stocks) | 23% Poorly correlated | +5.37% |
biotechnology theme (248 stocks) | 21% Poorly correlated | +5.56% |
biopharmaceuticals theme (52 stocks) | 20% Poorly correlated | +2.00% |
More |